{"id":4710,"date":"2015-09-24T09:34:58","date_gmt":"2015-09-24T09:34:58","guid":{"rendered":"https:\/\/jurmed.ro\/medici\/?post_type=tribe_events&#038;p=4710"},"modified":"2015-09-24T11:30:32","modified_gmt":"2015-09-24T11:30:32","slug":"sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300","status":"publish","type":"tribe_events","link":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/","title":{"rendered":"Sanofi cl\u0103de\u015fte viitorul \u00een tratarea diabetului de 90 de ani &#8211; Insulina de ultim\u0103 genera\u021bie Toujeo 300"},"content":{"rendered":"<p><strong>Rom\u00e2nia, \u00een primul val de \u0163\u0103ri europene \u00een care persoanele cu diabet vor avea acces la insulina bazal\u0103 de ultim\u0103 genera\u021bie<\/strong><\/p>\n<ul>\n<li><strong><em>Aproximativ jum\u0103tate dintre persoanele cu diabet nu \u00ee\u0219i ating \u021binta de control al glicemiei<\/em><\/strong><\/li>\n<li><strong><em>Insulina de ultim\u0103 genera\u021bie Toujeo (insulin\u0103 glargin 300 U\/ml) va fi compensat\u0103 integral \u00een Rom\u00e2nia<\/em><\/strong><\/li>\n<\/ul>\n<p><strong>Bucure\u0219ti, 24 septembrie 2015.<\/strong> Compania Sanofi, lider pe pia\u0163a de diabet din Rom\u00e2nia, anun\u021b\u0103 lansarea \u00een Rom\u00e2nia a Toujeo, <strong>insulina bazal\u0103 de ultim\u0103 genera\u021bie<\/strong> (insulin\u0103 glargin [de origine ADNr] injectabil\u0103, 300 U\/mL) indicat\u0103 pentru tratamentul adul\u021bilor cu diabet zaharat de tip 1 \u0219i 2. Noul produs a demonstrat un <strong>control glicemic stabil \u0219i prelungit<\/strong>, cu o durat\u0103 de ac\u0163iune de peste 24 de ore, cu o <strong>variabilitate redus\u0103 a glicemiei<\/strong>, la aceea\u0219i persoan\u0103, pe parcursul zilei<sup>1-3<\/sup>, \u00een compara\u021bie cu insulina glargin disponibil\u0103 p\u00e2n\u0103 \u00een acest moment (insulin\u0103 glargin [de origine ADNr] injectabil\u0103, 100 U\/mL).<\/p>\n<p><a href=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Lansare-insulina-de-ultima-generatie.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-medium wp-image-4718\" src=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Lansare-insulina-de-ultima-generatie-300x177.jpg\" alt=\"Lansare insulina de ultima generatie\" width=\"300\" height=\"177\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>Rom\u00e2nia, \u0163ara \u00een care Nicolae Paulescu a descoperit insulina, este \u00een primul val de \u0163\u0103ri europene \u00een care persoanele cu diabet vor avea acces la insulina bazal\u0103 de ultim\u0103 genera\u021bie. Conform Casei Na\u0163ionale de Asigur\u0103ri de S\u0103n\u0103tate, aproximativ 700.000 de rom\u00e2ni sufer\u0103 de diabet zaharat.<\/p>\n<p>Obiectivul tratamentului diabetului este de a aduce nivelurile de glucoz\u0103 din s\u00e2nge la \u021binta de control<sup>4 <\/sup>cu scopul de a reduce inciden\u0163a apari\u0163iei complica\u0163iilor micro \u015fi macrovasculare ale diabetului. \u00a0Totu\u0219i, aproximativ 50% dintre persoanele cu diabet, care urmeaz\u0103 un tratament cu insulin\u0103 sau nu, nu \u00ee\u0219i ating <strong>\u021binta de control a glicemiei<\/strong><sup>5-7<\/sup>.<\/p>\n<p><a href=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Prof-Dr-Cristian-Serafinceanu1.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-4715\" src=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Prof-Dr-Cristian-Serafinceanu1-222x300.jpg\" alt=\"Prof Dr Cristian Serafinceanu\" width=\"222\" height=\"300\" srcset=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Prof-Dr-Cristian-Serafinceanu1-222x300.jpg 222w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Prof-Dr-Cristian-Serafinceanu1.jpg 600w\" sizes=\"auto, (max-width: 222px) 100vw, 222px\" \/><\/a>\u201dDiabetul este asociat cu fluctua\u021bii rapide ale nivelului de glucoz\u0103 din s\u00e2nge, iar un control instabil al glicemiei poate duce la <strong>hiperglicemie sau hipoglicemie<\/strong>. Acestea pot contribui la apari\u0163ia mai precoce a complica\u0163iilor microvasculare (afectarea ocular\u0103, renal\u0103, a nervilor periferici) \u015fi macrovasculare (evenimente cardiovasculare). Un control deficitar al glicemiei, apari\u0163ia complica\u0163iilor, aderen\u021b\u0103 redus\u0103 la tratament \u015fi optimizarea stilului de via\u0163\u0103 contribuie la reducerea calit\u0103\u021bii vie\u021bii persoanei cu diabet \u0219i cre\u0219terea cheltuielilor de s\u0103n\u0103tate\u201d, a explicat <strong>Prof. Dr. Cristian Serafinceanu, Pre\u0219edinte al Societ\u0103\u021bii Rom\u00e2ne de Diabet, Nutri\u021bie \u0219i Boli Metabolice<\/strong>.<\/p>\n<p>Diabetul este o boal\u0103 evolutiv\u0103 \u015fi de aceea, de\u015fi exist\u0103 mai multe op\u0163iuni de tratament, multe persoane cu diabet de tip 2 au nevoie de insulin\u0103 pentru a ob\u021bine un <strong>control adecvat al glicemiei<\/strong><sup>8<\/sup>. \u00cen procesul de gestionare a diabetului, ini\u021bierea terapiei cu insulin\u0103 este uneori\u00a0 \u00eent\u00e2rziat\u0103 din diferite motive (iner\u0163ie clinic\u0103, team\u0103 de injectie, etc), unul dintre acestea fiind \u015fi teama de hipoglicemie<sup>9-10<\/sup>.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Prof-Dr-Nicolae-Hancu.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-4717\" src=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Prof-Dr-Nicolae-Hancu-227x300.jpg\" alt=\"Prof Dr Nicolae Hancu\" width=\"227\" height=\"300\" srcset=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Prof-Dr-Nicolae-Hancu-227x300.jpg 227w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Prof-Dr-Nicolae-Hancu.jpg 300w\" sizes=\"auto, (max-width: 227px) 100vw, 227px\" \/><\/a>\u201dInsulina bazal\u0103 analog este deja un <strong>standard pentru tratamentul<\/strong> persoanelor cu diabet zaharat tip 1 \u015fi 2. \u00cen acest context, insulina glargin s-a impus prin eficacitate \u015fi siguran\u0163\u0103 dovedite (hipoglicemie, siguran\u0163a cardiovascular\u0103), fiind insulina bazal\u0103 analog cea mai utilizat\u0103 \u00een practica medical\u0103 curent\u0103 din \u00eentreaga lume. Cu toate acestea, at\u00e2t medicul, c\u00e2t \u015fi pacientul se confrunt\u0103 cu necesitatea realiz\u0103rii echilibrului dintre <strong>controlul diabetului<\/strong> \u0219i <strong>riscul de hipoglicemie<\/strong>, ceea ce poate limita capacitatea de a optimiza tratamentul cu insulin\u0103 bazal\u0103. Aceasta duce la diminuarea \u00eencrederii pacien\u021bilor \u00een capacitatea de auto-control. De aceea, este binevenit\u0103 o nou\u0103 formulare de insulin\u0103 glargin care prin reducerea riscului de hipoglicemie, administrarea mai flexibil\u0103, controlul mai stabil al glicemiei pe durata a 24 ore, va \u00eembun\u0103t\u0103\u0163i at\u00e2t controlul diabetului, c\u00e2t \u015fi calitatea vie\u0163ii persoanelor cu diabet\u201d, a declarat <strong>Prof. Dr. Nicolae H\u00e2ncu, Membru de Onoare al Academiei Rom\u00e2ne \u0219i Pre\u0219edinte de Onoare al Federa\u021biei Rom\u00e2ne de Diabet, Nutri\u021bie \u0219i Boli Metabolice.<\/strong><\/p>\n<p>Eficacitatea \u0219i siguran\u021ba Toujeo au fost evaluate prin <strong>programul de studii clinice EDITION<\/strong>, care include mai multe studii interna\u021bionale de faz\u0103 III, care au inclus peste 3.500 de adul\u021bi cu diabet zaharat de tip 1 sau 2, necontrola\u021bi cu tratamentul lor actual<sup>11-16<\/sup>. Rom\u00e2nia s-a num\u0103rat printre \u021b\u0103rile incluse \u00een studiul EDITION, prin intermediul a numero\u015fi investigatori \u0219i pacien\u021bi.<\/p>\n<p>Noua insulin\u0103 \u0219i-a demonstrat capacitatea de a controla eficient glicemia, av\u00e2nd totodat\u0103, un <strong>profil de siguran\u021b\u0103 favorabil<\/strong>. \u00cen studiile derulate la pacien\u021bi cu diabet zaharat de tip 2, noua insulin\u0103 a demonstrat un <strong>risc semnificativ mai mic de episoade hipoglicemice<\/strong> diurne (\u00een orice moment al zilei) \u0219i nocturne, comparativ cu insulina glargin disponibil\u0103 p\u00e2n\u0103 \u00een acest moment (insulin\u0103 glargin [de origine ADNr] injectabil\u0103, 100 U\/mL)<sup>17<\/sup>.<\/p>\n<p>\u201eCu o experien\u0163\u0103 de peste 90 de ani \u00een tratarea diabetului zaharat, compania Sanofi are \u00een centrul tuturor demersurilor sale inova\u0163ia, cu scopul de a \u00eembun\u0103t\u0103\u0163i calitatea vie\u0163ii persoanelor cu diabet. Tradi\u0163ia bine stabilit\u0103 a Sanofi \u00een domeniul inova\u0163iei dateaz\u0103 \u00eenc\u0103 de la introducerea \u201eInsulinei Hoechst\u201d \u00een 1923, la numai doi ani dup\u0103 descoperirea acesteia de rom\u00e2nul Nicolae Paulescu. De atunci \u015fi p\u00e2n\u0103 acum, Sanofi a inovat \u00een permanen\u0163\u0103, \u015fi \u00een 2001, compania a lansat Lantus<sup>\u00ae<\/sup> (insulin\u0103 glargin) \u2013 o insulin\u0103 cu ac\u0163iune de lung\u0103 durat\u0103, de 24 de ore, administrat\u0103 o singur\u0103 dat\u0103 pe zi, care s-a impus ca standard \u00een tratamentul cu insulin\u0103 al diabetului zaharat. Ne bucur\u0103m c\u0103 ast\u0103zi Sanofi pune la dispozi\u0163ia comunit\u0103\u0163ii medicale \u015fi a persoanelor cu diabet din Rom\u00e2nia, la doar c\u00e2teva luni de la aprobarea european\u0103, o nou\u0103 genera\u0163ie de insulin\u0103 bazal\u0103 analog care ofer\u0103 siguran\u0163a necesar\u0103 pentru un control superior al diabetului zaharat\u201d, a declarat <strong>Dr. Eduard Pris\u0103cariu, Director Medical Sanofi Rom\u00e2nia<\/strong>. \u201eNoi privim dincolo de eficacitatea \u015fi siguran\u0163a medicamentelor noastre, fiind preocupa\u0163i permanent de cre\u015fterea calit\u0103\u0163ii vie\u0163ii persoanelor cu diabet\u201d, a completat <strong>Dr. Eduard Pris\u0103cariu<\/strong>.<\/p>\n<p>Noul produs este inclus pe lista de medicamente compensate integral \u0219i este disponibil prin intermediul unui <strong>stilou injector preumplut<\/strong>, care con\u021bine 450 de unit\u0103\u021bi de insulin\u0103 \u0219i care permite o doz\u0103 maxim\u0103 de 80 de unit\u0103\u021bi pentru o singur\u0103 injec\u021bie<sup>18<\/sup>. Stiloul prezint\u0103 elemente de design ergonomic, printre care o etichet\u0103 mai mare pentru citirea informa\u021biilor importante \u0219i diferen\u021bierea cromatic\u0103 clar\u0103, printr-un suport de cartu\u0219 colorat.<\/p>\n<p><a href=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Toujeo_Pen_Reflection_03_11_15-640x160.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-4712\" src=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Toujeo_Pen_Reflection_03_11_15-640x160-300x75.jpg\" alt=\"Toujeo_Pen_Reflection_03_11_15-640x160\" width=\"300\" height=\"75\" srcset=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Toujeo_Pen_Reflection_03_11_15-640x160-300x75.jpg 300w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/09\/Toujeo_Pen_Reflection_03_11_15-640x160.jpg 640w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>Toujeo a primit aprobarea din partea Administra\u021biei Americane pentru Alimente \u0219i Medicamente (FDA) \u015fi avizul pozitiv al Comitetului pentru Produse de Uz Uman (CHMP) din cadrul Agen\u0163iei Europene a Medicamentului (EMA) \u00een februarie 2015, fiind lansat \u00een Statele Unite ale Americii \u00een martie 2015. Produsul a fost aprobat \u00een Uniunea European\u0103 \u00een luna mai.<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Despre Divizia de Diabet a Sanofi <\/strong><\/p>\n<p>Sanofi \u015fi-a asumat angajamentul de a-i ajuta pe pacien\u0163i s\u0103 gestioneze provoc\u0103rile complexe pe care le presupune diabetul, prin solu\u0163ii inovatoare, integrate \u015fi personalizate. Pornind de la contribu\u0163iile valoroase ale persoanelor care tr\u0103iesc cu aceast\u0103 boal\u0103, compania \u00eencheie parteneriate pentru a oferi solu\u0163ii de diagnosticare, terapii, servicii \u015fi dispozitive, inclusiv sisteme inovatoare de monitorizare a glicemiei. Sanofi comercializeaz\u0103 medicamente injectabile, inhalabile \u015fi orale pentru persoanele cu diabet de tip 1 sau 2.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Despre Sanofi <\/strong><\/p>\n<p>Sanofi, lider mondial diversificat \u00een domeniul s\u0103n\u0103t\u0103\u0163ii, descoper\u0103, dezvolt\u0103 \u015fi distribuie solu\u0163ii terapeutice centrate pe nevoile pacien\u0163ilor. Sanofi de\u0163ine active puternice \u00een domeniul s\u0103n\u0103t\u0103\u0163ii, cu \u015fapte platforme de cre\u015ftere: solu\u0163ii pentru diabet, vaccinuri umane, medicamente inovatoare, produse medicale f\u0103r\u0103 prescrip\u0163ie, pie\u0163e emergente, s\u0103n\u0103tatea animalelor \u015fi noul Genzyme. Sanofi este cotat la Bursele din Paris (EURONEXT: SAN) \u015fi New York (NYSE: SNY).<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Referin\u0163e<\/strong><\/p>\n<ol>\n<li>Steinstraesser A, Schmidt R, Bergmann K, et al. Diabetes, Obesity and Metabolism. 2014;16(9):873-6, DOI: 10.1111\/dom.12283.<\/li>\n<li>Becker RHA, Dahmen R, Bergmann K, et al. Diabetes Care. 2014:epub ahead of print, DOI: 10.2337\/dc14-0006.<\/li>\n<li>Shiramoto M, Eto T, Irie S, et al. Diabetes, Obesity and Metabolism. 2014:epub ahead of print, DOI: 10.1111\/dom.12415.<\/li>\n<li>Inzucchi SE, et al. Diabetes Care. 2015;38(1):140-9. DOI: 10.2337\/dc14-2441<\/li>\n<li>Banegas JR, L\u00f3pez-Garc\u00eda E, Dallongeville J, et al. Eur Heart J. 2011;32(17):2143-52, DOI: 10.1093\/eurheartj\/ehr080.<\/li>\n<li>Vouri SM., et al. J Manag Care Pharm 2011;17:304\u2013312.<\/li>\n<li>Casagrande SS., et al. Diabetes Care 2013;36(8):2271\u20132279.<\/li>\n<li>Hirsch IB., et al. Clin Diabetes 2005;23(2):78\u201386.<\/li>\n<li>Polonsky WH., et al. Diabetes Care 2005;28(10):2543\u20132545.<\/li>\n<li>Ishii H. Plos one 2012;7(6):1\u20138.<\/li>\n<li>Riddle MC, Bolli GB, Ziemen M, et al. Diabetes Care. 2014;37(10):2755-62, DOI: 10.2337\/dc14-0991.<\/li>\n<li>Yki-J\u00e4rvinen H, Bergenstal R, Ziemen M, et al. Diabetes Care. 2014;37(12):3235-43, DOI: 10.2337\/dc14-0990.<\/li>\n<li>Bolli GB, Riddle MC, Bergenstal RM, et al. Diabetes, Obesity and Metabolism. 2015:epub ahead of print, DOI: 10.1111\/dom.12438.<\/li>\n<li>Home P, Bergenstal R, Riddle M, et al. 50th Annual Meeting of the European Association for the Study of Diabetes (EASD)2014.\u00a0 Oral presentation abstract #148.<\/li>\n<li>Matsuhisa M, Koyama M, Cheng X, et al. 50th Annual Meeting of the European Association for the Study of Diabetes (EASD)2014.\u00a0 Poster abstract #975.<\/li>\n<li>Terauchi Y, Koyama M, Cheng X, et al. 50th Annual Meeting of the European Association for the Study of Diabetes (EASD)2014.\u00a0 Poster abstract #976.<\/li>\n<li>Ritzel R, Roussel R, Bolli G, et al. 50th Annual Meeting of the European Association for the Study of Diabetes (EASD)2014.\u00a0 Poster abstract #963.<\/li>\n<li>Toujeo\u00ae EU Summary of Product Characteristics, 2015.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rom\u00e2nia, \u00een primul val de \u0163\u0103ri europene \u00een care persoanele cu diabet vor avea acces la insulina bazal\u0103 de ultim\u0103 genera\u021bie Aproximativ jum\u0103tate dintre persoanele cu diabet nu \u00ee\u0219i ating [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":4278,"template":"","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_tribe_events_status":"","_tribe_events_status_reason":"","footnotes":""},"tags":[399,402,398,233,400,401,86,87],"tribe_events_cat":[92],"class_list":["post-4710","tribe_events","type-tribe_events","status-publish","has-post-thumbnail","tag-control-a-glicemiei","tag-dr-eduard-prisacariu","tag-insulina","tag-insulina-glargin","tag-prof-dr-cristian-serafinceanu","tag-prof-dr-nicolae-hancu","tag-sanofi","tag-toujeo","tribe_events_cat-comunicate-de-presa","cat_comunicate-de-presa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sanofi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sanofi\" \/>\n<meta property=\"og:description\" content=\"Rom\u00e2nia, \u00een primul val de \u0163\u0103ri europene \u00een care persoanele cu diabet vor avea acces la insulina bazal\u0103 de ultim\u0103 genera\u021bie Aproximativ jum\u0103tate dintre persoanele cu diabet nu \u00ee\u0219i ating [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/\" \/>\n<meta property=\"og:site_name\" content=\"Jurmed - Medici\" \/>\n<meta property=\"article:modified_time\" content=\"2015-09-24T11:30:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/05\/sanofi2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"491\" \/>\n\t<meta property=\"og:image:height\" content=\"162\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:label1\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/\",\"url\":\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/\",\"name\":\"Sanofi\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/05\/sanofi2.jpg\",\"datePublished\":\"2015-09-24T09:34:58+00:00\",\"dateModified\":\"2015-09-24T11:30:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#primaryimage\",\"url\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/05\/sanofi2.jpg\",\"contentUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/05\/sanofi2.jpg\",\"width\":491,\"height\":162},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jurmed.ro\/medici\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\/\/jurmed.ro\/medici\/evenimente\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Sanofi cl\u0103de\u015fte viitorul \u00een tratarea diabetului de 90 de ani &#8211; Insulina de ultim\u0103 genera\u021bie Toujeo 300\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\",\"url\":\"https:\/\/jurmed.ro\/medici\/\",\"name\":\"Jurmed - Medici\",\"description\":\"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jurmed.ro\/medici\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sanofi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/","og_locale":"ro_RO","og_type":"article","og_title":"Sanofi","og_description":"Rom\u00e2nia, \u00een primul val de \u0163\u0103ri europene \u00een care persoanele cu diabet vor avea acces la insulina bazal\u0103 de ultim\u0103 genera\u021bie Aproximativ jum\u0103tate dintre persoanele cu diabet nu \u00ee\u0219i ating [&hellip;]","og_url":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/","og_site_name":"Jurmed - Medici","article_modified_time":"2015-09-24T11:30:32+00:00","og_image":[{"width":491,"height":162,"url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/05\/sanofi2.jpg","type":"image\/jpeg"}],"twitter_misc":{"Timp estimat pentru citire":"7 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/","url":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/","name":"Sanofi","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#primaryimage"},"image":{"@id":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/05\/sanofi2.jpg","datePublished":"2015-09-24T09:34:58+00:00","dateModified":"2015-09-24T11:30:32+00:00","breadcrumb":{"@id":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#primaryimage","url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/05\/sanofi2.jpg","contentUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2015\/05\/sanofi2.jpg","width":491,"height":162},{"@type":"BreadcrumbList","@id":"https:\/\/jurmed.ro\/medici\/eveniment\/sanofi-cladeste-viitorul-in-tratarea-diabetului-de-90-de-ani-insulina-de-ultima-generatie-toujeo-300\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jurmed.ro\/medici\/"},{"@type":"ListItem","position":2,"name":"Events","item":"https:\/\/jurmed.ro\/medici\/evenimente\/"},{"@type":"ListItem","position":3,"name":"Sanofi cl\u0103de\u015fte viitorul \u00een tratarea diabetului de 90 de ani &#8211; Insulina de ultim\u0103 genera\u021bie Toujeo 300"}]},{"@type":"WebSite","@id":"https:\/\/jurmed.ro\/medici\/#website","url":"https:\/\/jurmed.ro\/medici\/","name":"Jurmed - Medici","description":"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jurmed.ro\/medici\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"}]}},"_links":{"self":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tribe_events\/4710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/users\/5"}],"version-history":[{"count":1,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tribe_events\/4710\/revisions"}],"predecessor-version":[{"id":4716,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tribe_events\/4710\/revisions\/4716"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media\/4278"}],"wp:attachment":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media?parent=4710"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tags?post=4710"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tribe_events_cat?post=4710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}